Evidence map›Paper›PMID 24216113›Full record

Trial reportTrials2013

Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial.

Juan Li, Hui Zheng, Ling Zhao, Ying Li, Yan Zhang, Xiao-rong Chang, Rui-hui Wang, Jing Shi, Jin Cui, Yin-lan Huang and 4 more

Registry-linked trialOpen access · goldAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01701726 (Acupuncture for Patients With Mild Hypertension), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
6.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01701726 phase3completednot on this map

Acupuncture for Patients With Mild Hypertension: Study Protocol of an Open-label Multicenter Randomized Controlled Trial

TypeinterventionalSponsorChengdu University of Traditional Chinese MedicineRan2012 to 2016Enrolled400ConditionsEssential HypertensionArmsacupuncture, Sham acupuncture
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Acupuncture for patients with mild hypertension: A randomized controlled trial.Journal of clinical hypertension (Greenwich, Conn.) · 2019
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Acupuncture in Arterial Hypertension: Evaluation of its Efficacy with Both Office and Ambulatory Blood Pressure Measurements.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Juan Li
Hui Zheng
Ling Zhao
Ying Li
Yan Zhang
Xiao-rong Chang
Rui-hui Wang
Jing Shi
Jin Cui
Yin-lan Huang
Xiang Li
Jie Chen
De-hua Li
Fan-rong LiangChengdu University of Traditional Chinese Medicine Chengdu, Chengdu, Sichuan, PR China. acuresearch@126.com.
Chengdu University of Traditional Chinese Medicine · CNGuiyang College of Traditional Chinese Medicine · CNHunan University of Traditional Chinese Medicine · CNNingxia Medical University · CNShanxi University of Traditional Chinese Medicine · CNYunnan Provincial Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral studies using acupuncture to treat essential hypertension have been carried out. However, whether acupuncture is efficacious for hypertension is still controversial. Therefore, this trial aims to evaluate the efficacy and safety of acupuncture for patients with mild hypertension. METHODS/

designThis is a large scale, open-label, multicenter, randomized controlled clinical trial with four parallel arms. We will recruit 428 hypertensive patients with systolic blood pressure (SBP) between 140 and 159 mmHg, diastolic blood pressure (DBP) between 90 and 99 mmHg. The participants will be randomly assigned to four different groups (three acupuncture groups and one waiting list group) (1).The affected meridian acupuncture group (n = 107) is treated with acupoints on the affected meridians (2).The non-affected meridian acupuncture group (n = 107) is treated with acupoints on the non-affected meridians (3).The invasive sham acupuncture group (n = 107) is provided with sham acupoints treatment (4).The waiting-list group (n = 107) is not offered any intervention until they complete the trial. Each patient allocated to acupuncture groups will receive 18 sessions of acupuncture treatment over 6 weeks. This trial will be conducted in 11 hospitals in China. The primary endpoint is the change in average 24-hSBP before and 6 weeks after randomization. The secondary endpoints are average SBP and average DBP during the daytime and night-time, and 36-Item Short Form Survey (SF-36), and so on. DISCUSSION: This is the first large scale, multicenter, randomized, sham controlled trial of acupuncture for essential hypertension in China. It may clarify the efficacy of acupuncture as a treatment for mild hypertension.

trial registrationClinicaltrials.gov Identifier: NCT01701726.

Indexed as

Blood PressureResearch DesignAcupuncture PointsAcupuncture TherapyAdultAgedChinaClinical ProtocolsFemaleHumansHypertensionMaleMiddle AgedSeverity of Illness IndexTime FactorsTreatment Outcome

Identifiers

PMID24216113
PMCPMC4225756
OpenAlexW2100925610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.